Tivic Health Systems, Inc. TIVC 深 沪
已收盘 12-19 16:00:00 美东时间
1.74
-0.150
-7.94%
华盛通- 最 高1.9027
- 今 开1.87
- 成交量 2.99万股
- 最 低 1.74
- 昨 收 1.89
- 总市值 273.91万
- 52周最高 15.64
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.47
- 委 比 -48.15%
- 总股本 157.42万
- 历史最高 11050.00
- 量 比 0.72
- 振 幅 8.61%
- 历史最低 1.74
- 每 手 1
- 风险率 1.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tivic Health Acquires Strategic Manufacturing And Development Assets Of Scorpius Holdings; Launches Velocity Bioworks Subsidiary; Secures $16M Debt, Up To $75M Preferred Equity, And $50M Credit Line from 3i, LP
Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™Financing led by 3i, LP includes $16M debt
12-11 22:51
Tivic Health Systems Secures Techwatch Meeting With Biomedical Advanced Research and Development Authority's Radiological and Nuclear Medical Countermeasures Program Staff For for Acute Radiation Syndrome
Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company, today announced it has secured an exclusive Techwatch meeting with the Biomedical Advanced Research and Development Authority (BARDA)'s
11-18 21:35
Tivic Health Systems Q3 EPS $(2.00) Up From $(3.93) YoY, Sales $146.000K Up From $126.000K YoY
Tivic Health Systems (NASDAQ:TIVC) reported quarterly losses of $(2.00) per share. This is a 49.11 percent increase over losses of $(3.93) per share from the same period last year. The company reported $146.000 thousand
11-15 05:49
Earnings Scheduled For November 14, 2025
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
11-14 19:11
Tivic Health Systems Has Received A Notice Of Allowance For A U.S. Patent Titled "TMJ TREATMENT DEVICE WITH ADAPTIVE CIRCUIT"
https://patentcenter.uspto.gov/applications/18343848/ifw/docs
11-06 04:58
Tivic Health Systems Announces New CEO Employment Agreement
Tivic Health Systems ( ($TIVC) ) has provided an announcement. On October 8, 20...
10-16 05:18
Tivic Health Systems Completes Entolimod Cell Line Verification, Advancing CGMP In Preparation For Biologics License Application
Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that it has completed verification of its Entolimod™ cell line, the first step in establishing Current Good
09-10 20:41
Tivic Health Systems Appoints New Transfer Agent
An update from Tivic Health Systems ( ($TIVC) ) is now available. Tivic Health ...
08-28 04:29
Tivic Health Acquires Drug Applications from Statera Biopharma
The latest update is out from Tivic Health Systems ( ($TIVC) ). On August 20, 2...
08-20 20:58
Tivic Health Systems shares are trading higher after the company reported a year-over-year increase in Q2 EPS results.
Tivic Health Systems shares are trading higher after the company reported a yea...
08-15 04:04
